Your browser doesn't support javascript.
loading
Weekly Journal Scan: improved renal outcomes by semaglutide in patients with chronic kidney disease and type 2 diabetes in FLOW trial.
Pedicino, Daniela; Volpe, Massimo.
Affiliation
  • Pedicino D; Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Largo A. Gemelli 8, Rome 00168, Italy.
  • Volpe M; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Via di Grottarossa 1035, Rome, Italy.
Eur Heart J ; 45(38): 3910-3911, 2024 Oct 07.
Article in En | MEDLINE | ID: mdl-38985093

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Glucagon-Like Peptides / Renal Insufficiency, Chronic / Hypoglycemic Agents Limits: Humans Language: En Journal: Eur Heart J Year: 2024 Document type: Article Affiliation country: Italy Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Glucagon-Like Peptides / Renal Insufficiency, Chronic / Hypoglycemic Agents Limits: Humans Language: En Journal: Eur Heart J Year: 2024 Document type: Article Affiliation country: Italy Country of publication: United kingdom